CNP and Other metabolic disease: The results revealed the CNP–GCB–cGMP–VASP pathway in adipocytes and showed that the overexpression of CNP in adipocytes decreased adipocyte hypertrophy in WAT and ameliorated metabolic disorders during HFD-induced obesity in mice.